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Abstract
Background: Socioeconomic predictors and consequences of depression and its treatment were investigated in
4393 adults with specified non-communicable diseases attending 38 public sector primary care clinics in the Eden
and Overberg districts of the Western Cape, South Africa.
Methods: Participants were interviewed at baseline in 2011 and 14 months later, as part of a randomised
controlled trial of a guideline-based intervention to improve diagnosis and management of chronic diseases. The
10-item Center for Epidemiologic Studies Depression Scale (CESD-10) was used to assess depression symptoms,
with higher scores representing more depressed mood.
Results: Higher CESD-10 scores at baseline were independently associated with being less educated (p = 0.004)
and having lower income (p = 0.003). CESD-10 scores at follow-up were higher in participants with less education
(p = 0.010) or receiving welfare grants (p = 0.007) independent of their baseline scores. Participants with CESD-10
scores of ten or more at baseline (56 % of all participants) had 25 % higher odds of being unemployed at follow-
up (p = 0.016), independently of baseline CESD-10 score and treatment status. Among participants with baseline
CESD-10 scores of ten or more, antidepressant medication at baseline was independently more likely in
participants who had more education (p = 0.002), higher income (p < 0.001), or were unemployed (p = 0.001).
Antidepressant medication at follow up was independently more likely in participants with higher income
(p = 0.023), and in clinics with better access to pharmacists (p = 0.053) and off-site drug delivery (p = 0.013).
Conclusions: Socioeconomic disadvantage appears to be both a cause and consequence of depression, and may
also be a barrier to treatment. There are opportunities for improving the prevention, diagnosis and treatment of
depression in primary care in inequitable middle income countries like South Africa.
Trial registration: The trial is registered with Current Controlled Trials (ISRCTN20283604).
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Background
Depression is a common mental disorder, causing a high
level of disease burden. There were an estimated 298
million cases of major depressive disorder worldwide in
2010 [1] and this disorder was ranked the second leading
cause of years lived with disability (YLD) [1, 2].
Mental disorders are also an important cause of dis-
ease burden in South Africa. The South African Stress
and Health (SASH) study indicated a lifetime prevalence
of major depression of 9.7 % and a 12 month prevalence
of 4.9 % [3].
Approximately 80 % of South Africans are estimated
to be dependent on public health sector services [4],
which are inadequately equipped to address the high
prevalence of mental disorders. There is marked under-
treatment of mental disorders in primary care in South
Africa. Three quarters of adults with a mental disorder
in the SASH study received no treatment in the year of
the interview [5]. This treatment gap is consistent with
evidence from many low and middle income countries
(LMICs) [6].
South Africa is one of the most unequal countries in
the world [7], with wide disparities in wealth and health
[8]. Income inequality has been shown to be positively
associated with mental illness [9–11]. A study among
older Americans found those living in counties with
higher income inequality were more depressed, inde-
pendent of their demographic characteristics, socioeco-
nomic status, and physical health [10]. In South Africa,
the burden of ill-health has been demonstrated to be
greater among lower socio-economic groups [12].
A number of studies in LMICs have shown an asso-
ciation between indicators of poverty and mental dis-
orders [11, 13]. A systematic review of the
relationship between poverty and common mental
disorders in LMICs found a relatively consistent and
strong association between common mental disorders
and education, food insecurity, housing, social class,
socio-economic status and financial stress; whereas
income, employment and consumption were found to
be more equivocal [11]. A second systematic review
of poverty and common mental disorders in develop-
ing countries found most studies showed an associ-
ation between risk of common mental disorders and
low levels of education, and many studies also showed
a relationship with other indicators of poverty such as
poor housing or low income [13].
Associations have been found between depression and
non-communicable diseases. High depression scores
have been found to be an independent risk factor for
hypertension, and there is evidence for an association
between mental disorder and diabetes. In addition, de-
pression has been shown to be associated with poor gly-
caemic control [14].
Depression has been shown to be associated with
more frequent exacerbations in patients with chronic
obstructive pulmonary disease (COPD), worse short-
term survival, and higher rates of post-exacerbation re-
admission to hospital. An interaction effect has also
been reported between symptoms of depression and
death among patients with COPD [15].
The majority of past studies looking at socio-
economic associations with depression in LMICs have
been cross-sectional, making it difficult to draw conclu-
sions on causality [11]. Two explanations have been pro-
posed for the inverse relationship between psychiatric
disorders and socioeconomic status. Social causation
postulates that adversity and stress due to conditions of
poverty increase the risk of mental illness, whereas social
selection/drift postulates that people with mental illness
are at increased risk of drifting into or remaining in pov-
erty due to factors such as loss of employment, reduced
productivity, stigma and increased health expenditure
[16]. Although these causal pathways are complex, evi-
dence suggests social causation may be more important
for common mental disorders such as depression, par-
ticularly in women, while social selection/drift processes
may be more important for schizophrenia [17].
Few studies have addressed predictors of change in de-
pression symptoms, and predictors of change in treat-
ment for depression over time in LMICs. In addition,
few studies have explored the health and economic im-
pact of depression over time.
The aims of this cohort study were to investigate the
extent to which socioeconomic position and physical ill-
ness (hypertension, diabetes, chronic respiratory disease)
predict depression symptoms over time among primary
care attenders, and the extent to which these factors and
health service characteristics predict treatment of de-
pression over time.
Methods
Study design and context
This paper reports on a cohort study within a cluster ran-
domised controlled trial (RCT), including cross-sectional
baseline data and longitudinal data on changes from base-
line to follow up. The aim of the RCT was to evaluate the
effectiveness of the Primary Care 101 guideline training
programme for primary health care providers [18, 19], and
to assess whether the programme improved quality of care
for specified chronic diseases. Primary Care 101 consists
of three elements: a 101-page algorithmic guideline that
covers common symptoms and conditions in adults; an
educational outreach programme in which nurse trainers
deliver interactive training sessions on-site to all staff at a
facility, using the Primary Care 101 guideline and case sce-
narios; and additional prescribing provisions for nurses
who successfully complete their training.
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Thirty-eight clinics in the Eden and Overberg districts
of the Western Cape, South Africa, were cluster rando-
mised either to receive the Primary Care 101 training
programme for health care providers, or to continue
with usual care. Eligible patients, defined below, who
provided consent were interviewed at baseline in 2011
and once more, 14 months later [19]. The analyses for
this study included data from the whole RCT cohort at
baseline and follow-up, combining the intervention and
control arms.
Study population and sample
The study population comprised adults attending public
sector primary care clinics in two districts of the
Western Cape province of South Africa. The communi-
ties served by the public sector clinics in these two dis-
tricts are characterised by high levels of unemployment
and socio-economic deprivation. In 2011, unemploy-
ment rates were 22.5 and 17.0 % in the Eden and Over-
berg districts respectively [20], and the Eden district was
rated as the poorest in the Western Cape province [21].
The study site is typical of many low resource rural and
small urban settings in South Africa, in which the public
sector primary health care clinics are nurse-led with
some doctor support.
Thirty-eight of the largest primary care clinics in the
Eden district and two Overberg sub-districts were se-
lected. Each clinic services at least 10 000 attendances
per year and they are staffed by nurse practitioners, doc-
tors and community health workers. The study popula-
tion was restricted to adults 18 years or older, planning
to reside in the area for the next year, and capable of ac-
tively engaging in an interviewer-administered question-
naire at the time of recruitment.
Among patients who met these criteria, four groups
representing patients with hypertension, diabetes,
chronic respiratory disease and depression were identi-
fied. Patients were eligible for the hypertension and dia-
betes groups if they reported being on medication for
hypertension or diabetes respectively. They were eligible
for the respiratory group if they reported being on medi-
cation for chronic respiratory disease, or had symptoms
of chronic respiratory disease and were not on treatment
for tuberculosis. Patients were eligible for the depression
group if they scored ten or more on the 10-item Centre
for Epidemiologic Studies Depression Scale (CESD-10)
[22]. Patients may have fulfilled inclusion criteria for
more than one disease group. Participants were sampled
consecutively within each clinic and invited to partici-
pate in the study, until the sample size required for each
clinic was obtained. They were screened for eligibility by
orally questioning them and, if they met the eligibility
criteria, were then asked to provide informed consent to
participate.
Data collection and coding
At baseline trained fieldworkers administered the elec-
tronic questionnaire and took clinical measurements
after eligible participants provided informed consent.
The baseline questionnaire included questions about
demographic characteristics, comorbidities, and socio-
economic factors. Participants were asked about the
highest level of education they had achieved (no school-
ing, grade 1–7, grade 8–12 or tertiary/diploma), their
employment status (employed, self-employed, student/
learner or unemployed), and their employed and pen-
sion/grant income in the last month.
The presence of depression symptoms was assessed
with the 10-item CES-D scale which was administered
to all participants. The 20-item CES-D was originally
developed by Radloff (1977) to measure symptoms of
depression in the general population [23, 24]. A
shortened 10-item version was created by Andresen
et al. [22] The CESD-10 items are: “1. I was bothered
by things that usually don't bother me. 2. I had
trouble keeping my mind on what I was doing. 3. I
felt depressed. 4. I felt that everything I did was an
effort. 5. I felt hopeful about the future. 6. I felt fear-
ful. 7. My sleep was restless. 8. I was happy. 9. I felt
lonely. 10. I could not get going.” The individual
items are scored from 0 (rarely or none of the time)
to 3 (most of the time) and a score is assigned by to-
talling all item scores. The possible range of scores is
0–30 for the 10-item scale, with higher scores repre-
senting greater degrees of depressed mood [22]. Both
the 10- and 20- item CES-D have been used and vali-
dated in a number of countries including among HIV
infected individuals in South Africa [25, 26].
All participants were asked if they had received psy-
chological counselling in the year leading up to their
baseline interview. Counselling was defined as talking
with someone in a way that helps to find solutions to
problems, or receive emotional support, and not just re-
ceiving advice on how to take medication. Participants
who reported receiving counselling from a mental health
nurse, clinic counsellor, social worker, psychiatrist or
psychologist were considered to have received counsel-
ling. Participants who reported receiving counselling
from a mental health nurse, psychiatrist or psychologist
were considered to have been referred to psychiatric
services.
Chronic medication prescribed at the time of each par-
ticipant’s interview for depression, hypertension, diabetes
and respiratory disease was recorded. Fieldworkers
photocopied all available prescription charts for the year
preceding the interview. The trial manager (NF) ana-
lysed the prescription charts to identify medication for
chronic conditions prescribed for each participant at the
time of their interview.
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It is common practice in the Eden and Overberg dis-
tricts for amitriptyline or imipramine to be prescribed at
a low dose (25 mg daily) for pain management and in-
somnia. We considered amitriptyline and imipramine at
a dose less than 50 mg daily to be sub-therapeutic for
depression [6]. Other antidepressants were not pre-
scribed at sub-therapeutic doses [27]. We therefore de-
fined being on an antidepressant at a therapeutic dose as
prescription of amitriptyline or imipramine of 50 mg or
more daily, or on any other antidepressant.
Disease-specific control indicators were measured at
baseline and follow-up [19]. Systolic and diastolic blood
pressure were measured in all participants. Ten year risk
of cardiovascular deaths was calculated, based on age,
sex, systolic blood pressure, smoking status, reported
diabetes and body mass index [28]. The severity of re-
spiratory disease was assessed with the Symptom and
Activity domains of the St Georges Respiratory Ques-
tionnaire (SGRQ) [29] in participants enrolled in the re-
spiratory disease group. Glycated haemoglobin (HbA1c)
was measured in a sub-sample of 704 diabetic partici-
pants from 20 randomly selected clinics.
The following clinic characteristics were identified at
baseline: availability of a pharmacist, availability of drug
supply away from clinic, psychiatric nurse at clinic, doc-
tor at clinic every day, clinic location, clinic patients per
year, clinic patients per nurse per year, and intervention
versus control clinic.
At follow-up the questionnaire, clinical measurements
and prescription data were collected and recorded as for
the baseline data. Baseline data collection began in
March 2011 and ended in October 2011. Follow-up data
collection started in May 2012 and ended in January
2013.
Statistical methods
The statistical analyses investigated associations between
participants’ health and socioeconomic indicators, and
their symptoms and treatment of depression. We also in-
vestigated associations between depression symptoms re-
ported at baseline and subsequent changes in participants’
income and employment, ten year risk of death from car-
diovascular disease and, in participants with hypertension,
diabetes, or respiratory disease, in blood pressure control,
glycaemic control and respiratory symptoms respectively.
Analyses of treatments included the following clinic char-
acteristics as potential explanatory variables: pharmacist in
clinic, drug supply available away from clinic, psychiatric
nurse at clinic, doctor at clinic every day, clinic location,
clinic patients per year, clinic patients per nurse per year,
and intervention versus control clinic. These clinic charac-
teristics were investigated because they could potentially
influence access to necessary treatment directly, or be in-
direct indicators of the quality of care.
In all analyses the study’s cluster sampling design
was accounted for in regression models with robust
adjustment for intra-clinic cluster correlation of out-
comes, using Stata version 12.0 statistical software
[30]. A p value 0.05 or less was considered statisti-
cally significant.
Intervention or control arm of the randomised con-
trolled trial was accounted for in all longitudinal ana-
lyses. Variables independently associated with the
outcome in each model were selected using backwards
stepwise selection. At each step, explanatory variables
with a p value of less than 0.10 were removed from each
model. The purpose of stepwise selection of explanatory
variables for each model was to estimate the effects of
each socioeconomic indicator without confounding by
other socioeconomic indicators or patient characteris-
tics. Even though all of the socioeconomic indicators
could theoretically have causally influenced depression
and its care, it was not appropriate to keep all of them
in every model because of the likelihood that overadjust-
ment for collinear variables would obscure relevant
associations.
The primary analyses of variables associated with de-
pression symptoms were multiple linear regression
models with CESD-10 score as the continuous outcome
variable. Secondary analyses of depression symptoms
used multiple logistic regression models with CESD-10
scores coded as high (greater than or equal to ten) or
low (less than ten).
Analyses with treatments (antidepressant medication,
counselling, or referral to psychiatric services) as out-
comes were confined to participants with CESD-10
scores greater than or equal to ten at baseline and used
multiple logistic regression models. Primary analyses of
antidepressant medication coded treatment as present
only if drug doses were defined as therapeutic. Second-
ary analyses coded antidepressant treatment as present
at any dose.
Longitudinal data analysis was as follows. Changes
between baseline and follow-up in depression symp-
toms, antidepressant medication, employment or in-
come used analysis of covariance (ANCOVA) in the
multiple regression models, that is, with the follow-up
variable as outcome and with the baseline variable as
a covariate. This was done to account for regression
to the mean, that is, individuals with exceptionally
high or low values at baseline would at follow-up
tend to have values closer to the mean, due to chance
alone [31]. Analyses of changes all included trial arm
as a potential explanatory variable.
The trial is registered with Current Controlled Trials
(ISRCTN20283604). Ethical approval for the trial was
obtained from the University of Cape Town Human Re-
search Ethics Committee and the Western Cape
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Provincial Department of Health. All participants pro-
vided informed consent to participate in the study.
Results
A total of 4393 participants were enrolled at baseline, of
whom 90.5 % were followed up. Prescription records
were available for 4364 (99.3 %) participants at baseline
and 4284 (97.5 %) participants at follow up.
Table 1 shows the socio-demographic characteristics
of participants at baseline. The majority of participants
(73 %) were women and half were over the age of
50 years. Seventy-four percent had hypertension, 42 %
had diabetes, 26 % had chronic respiratory disease or
symptoms and 56 % had CESD-10 scores of ten or more.
The majority of participants had not completed second-
ary school education (52 %), were unemployed (75 %)
and receiving a welfare grant (58 %). The average
monthly income was equivalent to about US$4.90 per
day in 2011 [32], but this includes 26 % who reported
having no income. These socioeconomic indicators were
all significantly associated with each other, except that
non-grant income was not associated with language
group.
Baseline CESD-10 scores had a mean value of 10.8
units (standard deviation (SD) 6.4, median 11, interquar-
tile range 6 to 15). Change in CESD-10 scores had a
mean value of 3.1 units (SD 7.0, median 7, interquartile
range −1 to 8). Both baseline and change in CESD-10
score had symmetrical bell-shaped distributions, except
that the baseline score was truncated at zero. However
both distributions were significantly different from Nor-
mal according to Stata’s combined skewness and kurtosis
tests for Normality. At baseline, CESD-10 scores were
positively associated with female sex, chronic respiratory
disease, antidepressant use and housing density, and
were inversely associated with age, hypertension, dia-
betes and income.
Linear regression models estimated the independent
associations of CESD-10 scores with the health and so-
cioeconomic indicators (Table 2). Baseline CESD-10
scores were higher in participants who had chronic re-
spiratory disease, were unemployed or receiving a wel-
fare grant, and were lower in participants who were
older, male, had hypertension or diabetes, were more ed-
ucated or had higher incomes at baseline. CESD-10
scores at follow-up had increased since baseline in par-
ticipants who had chronic respiratory disease, spoke
Xhosa, or received welfare grants. CESD-10 scores at
follow-up were lower in participants who were older,
male, had hypertension, or were more educated at
baseline.
The secondary analyses mostly confirmed the ro-
bustness of the results reported in Table 2, as follows.
An equivalent logistic regression model with higher
(greater than or equal to ten) versus lower baseline
CESD-10 scores as binary outcome found the same
variables as in Table 2 to be significant predictors, ex-
cept that language was not significant (p = 0.360), and
employment was (p = 0.013). Housing density was not
independently associated with CESD-10 score as a
continuous outcome variable (p = 0.148), but was as-
sociated with higher CESD-10 score modelled as a
binary outcome variable (p = 0.05). Logistic regression
with higher CESD-10 score at follow-up as a binary
outcome variable, adjusted for baseline CESD-10
score, found age, sex, chronic respiratory disease, edu-
cation and welfare grant, but not hypertension, to be
significant predictors. Greater housing density was in-
dependently associated with increasing CESD-10
scores in linear and in logistic regression models.
Participants with CESD-10 scores of ten or more at
baseline had 25 % higher odds of being unemployed at
follow-up, and had R55 higher income per month from
welfare grants at follow-up, independently of their em-
ployment status or grant income at baseline, and other
confounding variables (Table 3). Baseline CESD-10
scores were not independently associated with changes
in non-grant income or total income.
Baseline CESD-10 score, whether coded as a continu-
ous or binary variable, was not associated with changes
in blood pressure control, glycaemic control, respiratory
symptom score or ten year risk of death from cardiovas-
cular disease.
Logistic regression models estimated the independ-
ent effects of participant and clinic characteristics on
antidepressant medication at baseline and follow-up,
among participants with baseline CESD-10 scores of
ten or more, and who consequently may have bene-
fited from diagnosis and treatment of their depression
symptoms (Table 4). Receipt of any treatment (anti-
depressant medication, counselling or psychiatric re-
ferral) was more likely in participants with higher
CESD-10 scores in every model. Antidepressant medi-
cation at therapeutic doses at baseline was more likely
in participants with more education, higher income,
unemployed, or in clinics with a pharmacist, and was
less likely in males and Xhosa speakers, independently
of their baseline CESD-10 score. In the case of educa-
tion, there appeared to be a dose–response relation-
ship, indicated by a steady increase in treatment
access with more years of education. Receipt of thera-
peutic doses of antidepressant drug at follow-up was
more likely in women, participants with higher in-
come or in clinics with a pharmacist, drugs supplied
off-site, daily doctor support, lower patient to nurse
ratios, or peri-urban or rural location, independently
of baseline CESD-10 score and antidepressant
medication.
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Table 1 Participants’ baseline characteristics and associations with baseline CESD-10a scores
Numberb Percentb CESD-10 Mean CESD-10 SD pc
Health indicators
Age (years): mean (SD) 51.6 (13.5) n = 4393 <0.001
Sex <0.001
• Women 3193 72.7 11.2 6.4
• Men 1199 27.3 9.7 6.2
Hypertension <0.001
• No 1166 26.6 12.8 6.2
• Yes 3226 73.5 10.0 6.3
Diabetes <0.001
• No 2551 58.1 11.8 6.4
• Yes 1841 41.9 9.3 6.0
Chronic respiratory Disease <0.001
• No 3235 73.7 10.2 6.3
• Yes 1157 26.3 12.2 6.4
CESD-10 score ≥10
• <10 1926 43.9 4.9 2.8
• ≥10 2466 56.2 15.3 4.3
Antidepressant, any dose <0.001
• No 3545 81.3 10.2 6.1
• Yes 818 18.8 13.2 7.0
Antidepressant, therapeutic dose <0.001
• No 3971 91.0 10.3 6.1
• Yes 392 9.0 15.1 7.3
Socioeconomic indicators
Language 0.88
• Afrikaans 3679 83.8 10.8 6.6
• Xhosa 337 7.7 10.1 5.3
• English 376 8.6 10.6 5.3
Highest education 0.35
• None 291 7.3 10.8 6.2
• Primary 1757 44.2 11.0 6.2
• Secondary 1853 46.6 10.6 6.5
• Tertiary 75 1.9 9.9 6.4
Total monthly income (Rand): mean (SD) 1084 (1254) n = 4378 <0.001
Unemployed 0.12
• No 1096 25.0 10.4 6.4
• Yes 3282 75.0 10.9 6.4
Welfare grant 0.87
• No 1850 42.3 10.7 6.4
• Yes 2528 57.7 10.8 6.4
Housing density (occupants/rooms): mean (SD) 1.8 (1.2) n = 2930 <0.001
a CESD-10 10-item Center for Epidemiologic Studies Depression Scale
b Except mean and standard deviation (SD) for continuous variables
c Linear regression models adjusted for cluster sample design
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Psychiatric referral between baseline and follow-up
was more likely in participants with tertiary education or
higher income and was less likely in participants who
were older, male, Xhosa-speaking or in intervention
clinics.
Counselling between baseline and follow-up was more
likely in participants with more education or receiving
welfare grants, and in clinics that supplied drugs away
from the clinics, and was less likely in participants who
were older or had hypertension, and in intervention
clinics or clinics with a psychiatric nurse.
Discussion
This study shows that depression symptoms in adults at-
tending primary care clinics in two districts of South
Africa, most of whom had common chronic conditions,
were strongly and independently associated with several
indicators of disadvantaged socioeconomic position. De-
pression symptoms, as indicated by higher CESD-10
scores at baseline, were independently associated with
being less educated and having lower income. CESD-10
scores at follow-up had increased since baseline in par-
ticipants who were less educated or receiving welfare
grants. Level of education was however not associated
with baseline CESD-10 score in the crude analysis, being
confounded by the other socioeconomic indicators. This
is consistent with findings from several other LMICs,
where education was less frequently associated with
common mental disorders in bivariate analyses than in
multivariate analyses [11].
Previous studies, the majority of which have been
community based, have similarly demonstrated associa-
tions between common mental disorders and socioeco-
nomic factors, including less education [11, 13, 33, 34],
low socio-economic status [11] and low income [13, 34].
Our study population comprised patients already using
primary care facilities, and therefore relatively easy to
reach for diagnosis and treatment of depression. It
showed that, at baseline, participants were less likely to
have received treatment with antidepressants if they
were socially disadvantaged, in particular if they had
lower income or less education. However, participants
were more likely to receive treatment if they were un-
employed. This may be because it is easier for un-
employed participants to attend clinics for treatment. In
contrast, the SASH study found no significant associa-
tions between receiving treatment for mental disorders
and income or level of education [35]. At follow-up,
clinic characteristics were more important than socio-
economic factors in predicting depression treatment,
Table 2 Patients’ baseline characteristics independently associated with CESD-10a score at baseline and with changeb in CESD-10
score: linear regression models
Outcome Baseline CESD-10a score Follow-up CESD-10a scoreb
Explanatory variable Coefficient 95 % CIa p Coefficient 95 % CIa p
Age (per year) −0.06 −0.08 −0.04 <0.001 −0.06 −0.08 −0.04 <0.001
Men vs. women −1.66 −2.19 −1.13 <0.001 −0.96 −1.46 −0.46 <0.001
Hypertension −1.93 −2.60 −1.27 <0.001 −0.53 −1.07 0.00 0.052
Diabetes −1.75 −2.27 −1.24 <0.001
Chronic respiratory disease 1.21 0.51 1.91 <0.001 1.06 0.58 1.54 <0.001
Highest education 0.004c 0.010c
• None (reference) 1.00 1.00
• Primary −0.24 −1.31 0.84 0.656 −0.35 −1.34 0.63 0.473
• Secondary −1.19 −2.33 −0.05 0.042 −1.48 −2.50 −0.47 0.005
• Tertiary −0.93 −2.70 0.83 0.291 −1.64 −3.03 −0.25 0.022
Language 0.038c
• Afrikaans (reference) 1.00
• Xhosa 1.90 0.42 3.37 0.013
• English 1.66 −0.66 3.98 0.156
Income (per 1000 Rand per month) −0.23 −0.37 −0.08 0.003
Unemployed 0.53 −0.08 1.15 0.086
Welfare grant baseline 0.54 −0.02 1.10 0.060 0.66 0.19 1.13 0.007
Baseline CESD-10 scoreb NA 0.32 0.27 0.37 <0.001
a CESD-10 10-item Center for Epidemiologic Studies Depression Scale, CI confidence interval, NA not applicable
b Change modelled with analysis of covariance, that is, with baseline value as covariate
c Wald test for all categories of variable
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with participants less likely to have received antidepres-
sant medication if they attended less resourced clinics,
without a pharmacist or off-site drug delivery, or if they
had lower income. Primary care clinics should be ad-
equately staffed and have pharmacists on site but also
enable patients to collect their repeated medicines at
more convenient locations. Strategies to deal with the
shortage of doctors and nurses in the South African
public sector, especially in rural areas, have included
community service for doctors, monetary incentives,
introducing a cadre of mid-level workers such as phar-
macists, contracting non-professional health workers to
take on various responsibilities such as counselling and
adherence support, and introducing innovative clinical
guidelines to enable nurses to manage patients who
would otherwise be seen by doctors [36]. Nevertheless,
our results reflect the effects of variation in patient:staff
ratios within a resource-constrained system, and suggest
the need to equalise workloads between clinics, with
existing resources. Our finding that patients in clinics
with a psychiatric nurse were less likely to receive coun-
selling at follow-up is counter-intuitive. It may be that
psychiatric nurses are managing patients with more se-
vere psychiatric disease, that is, psychoses mostly treated
with drugs, and do not have the time or skills to provide
counselling for depression.
Patients who were more depressed at baseline were
more likely to receive antidepressant medication subse-
quently. Causal inference about the cross-sectional asso-
ciation between depression symptoms at baseline and
treatment at baseline is not as clear, but it is more plaus-
ible that depression led to treatment rather than that
treatment led to depression. Women were more likely
than men to have higher CESD-10 scores and to receive
treatment with antidepressants at baseline and follow-
up. These findings are consistent with work from HIV
cohorts in Southern Africa which have shown that pro-
portionally more women than men are on antiretroviral
therapy [37], and highlights the need to identify barriers
to men accessing healthcare [38, 39]. The role of gender
in the causation, experience, reporting and care of de-
pression is however an enormous subject which was be-
yond the scope of this study.
Depression could potentially have affected participants’
physical health through biological mechanisms, or
through their health care use, treatment adherence or
interpretation of physical symptoms. However, we found
that depression symptoms at baseline were not associ-
ated with changes in blood pressure control, glycaemic
control, respiratory symptom score or ten year risk of
death from cardiovascular disease. This differs from
studies which have shown a positive association between
Table 3 Patient characteristics independently associated with changesa in unemployment and welfare grant income: logistic and
linear regression models
Outcome Unemployed at follow-upb Monthly welfare grant income at follow up (Rand)c
Explanatory variable ORd 95 % CI p Coefficient 95 % CId p
CESD-10 score≥10 at baseline 1.25 1.04 1.51 0.016 55 18 91 0.004
Age (per year) 1.05 1.04 1.06 <0.001 9 7 11 <0.001
Men vs. women 0.70 0.57 0.86 0.001
Chronic respiratory disease 66 25 108 0.003
Diabetes 27 0 55 0.048
Highest education <0.001e 0.017 e
• None (reference) 1.00 0
• Primary 0.78 0.54 1.13 0.186 −38 −85 8 0.105
• Secondary 0.59 0.38 0.90 0.014 −67 −115 −19 0.007
• Tertiary 0.19 0.10 0.35 <0.001 3 −212 218 0.975
Language 0.052e <0.001e
• Afrikaans (reference) 1.00 0
• Xhosa 0.68 0.46 1.00 0.047 −158 −228 −88 <0.001
• English 1.21 0.85 1.73 0.288 −99 −162 −37 0.003
Unemployed at baselinea 13.9 10.7 18.2 <0.001
Grant income at baseline (per 1000 Rand per month)a 602 522 682 <0.001
a Change modelled with analysis of covariance, that is, with baseline value as covariate
b Logistic regression model
c Linear regression model
d OR odds ratio, CI confidence interval
e Wald test for all categories of variable
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Table 4 Baseline health, socioeconomic and clinic characteristics independently associated with mental health treatments at baseline and at follow-upa, in patients with CESD-
10 score of ten or more: logistic regression models
Outcome Therapeutic dose of antidepressant
drug at baseline
Therapeutic dose of antidepressant
drug at follow-upa




ORb 95 % CIb P OR 95 % CI P OR 95 % CI P OR 95 % CI P
Patient
characteristics
Age (per year) 0.97 0.95 0.98 <0.001 0.97 0.96 0.98 <0.001
Men vs. women 0.31 0.19 0.49 <0.001 0.34 0.22 0.53 <0.001 0.67 0.43 1.03 0.069
Hypertension 0.75 0.60 0.95 0.016
Diabetes 0.72 0.49 1.06 0.094 0.71 0.48 1.04 0.079
Highest education 0.002c 0.006c 0.022c
• None (reference) 1.00 1.00 1.00
• Primary 1.36 0.75 2.47 0.314 1.11 0.51 2.38 0.797 0.85 0.51 1.41 0.529
• Secondary 1.98 1.10 3.55 0.022 1.37 0.62 2.99 0.435 0.81 0.49 1.33 0.401
• Tertiary 2.06 0.91 4.66 0.082 4.00 1.57 10.15 0.004 1.99 1.08 3.68 0.028
Language <0.001c 0.003c
• Afrikaans (reference) 1.00 1.00
• Xhosa 0.23 0.15 0.35 <0.001 0.16 0.05 0.45 0.001
• English 0.85 0.54 1.35 0.488 1.10 0.64 1.90 0.732
Income (per 1000 rand per
month)
1.31 1.18 1.44 <0.001 1.21 1.03 1.43 0.023 1.19 1.05 1.34 0.005
Unemployed 2.01 1.32 3.09 0.001
Welfare grant 1.35 0.96 1.90 0.082 1.36 1.13 1.64 0.001
Baseline CESD-10 score (per
unit)
1.15 1.12 1.19 <0.001 1.06 1.00 1.11 0.033 1.11 1.06 1.15 <0.001 1.06 1.03 1.10 <0.001
Therapeutic dose of
antidepressant at baselinea
NAb 136.90 77.25 242.61 <0.001 NA NA
Clinic characteristics
Pharmacist in clinic 1.86 1.25 2.78 0.002 1.58 0.99 2.51 0.053
Drug supply available away
from clinic
1.67 1.11 2.50 0.013 1.59 0.95 2.66 0.078
Psychiatric nurse at clinic 0.32 0.13 0.80 0.015
Doctor at clinic every day 1.48 0.95 2.30 0.084
Clinic location 0.038c













Table 4 Baseline health, socioeconomic and clinic characteristics independently associated with mental health treatments at baseline and at follow-upa, in patients with CESD-
10 score of ten or more: logistic regression models (Continued)
• Peri-urban 1.17 0.66 2.08 0.599
• Rural 2.60 1.18 5.76 0.018
Clinic patients per year/10,000 1.04 0.99 1.10 0.081
Clinic patients per nurse per year/1000 0.93 0.88 0.99 0.022
Intervention vs. control clinic 1.39 0.97 1.98 0.073 0.57 0.35 0.91 0.020 0.54 0.33 0.88 0.013
a Change modelled with analysis of covariance, that is, with baseline value as covariate
b OR odds ratio, CI confidence interval, NA not applicable













depression and poor glycaemic control in diabetic pa-
tients [14].
Our findings suggest that the association between de-
pression symptoms and socio-economic position is bidir-
ectional. That is, in addition to disadvantaged social
position predicting worse depression symptoms at
follow-up, participants who had depression symptoms at
baseline were more socially disadvantaged at follow-up,
showing 25 % higher odds of being unemployed. The bi-
directional link between depression symptoms and social
disadvantage therefore supports both the social caus-
ation and social selection theories. Our findings suggest
that, in this study setting, socioeconomic disadvantage is
both a cause and a consequence of depression, and may
also be a barrier to treatment, with participants less
likely to receive treatment if they had a lower income
(baseline and follow-up) or less education (baseline).
The study had a number of strengths. The sample size
was large, high rates of follow-up were achieved, and a
wide range of socio-economic variables were investi-
gated. A key strength of the study was the longitudinal
design, which allowed potential causal relationships to
be identified, demonstrating that the relationship be-
tween socioeconomic position and depression worked in
both directions.
There were a number of limitations to the study. The
CESD-10 questionnaire was used to identify participants
with depression symptoms, but not to confirm the clin-
ical diagnosis of depression. It was originally derived and
validated on an older adult population [22] but has sub-
sequently been validated in a younger population on
antiretroviral therapy [25]. Participants were only en-
rolled into the study if they had hypertension, diabetes,
chronic respiratory disease or depression symptoms, so
the results may not be generalisable to primary care at-
tenders without these conditions. Thirty-four percent of
participants in the depression group did not answer the
question at baseline on whether they had received coun-
selling in the past year. This was due to an error in the
electronic questionnaire that resulted in this question
being skipped during several weeks of fieldwork before it
was detected and corrected. Socioeconomic factors that
could influence depression symptoms that were not
measured include food insecurity, poor housing, lack of
social support, and disability.
Further research is needed to investigate the relative
contributions of both social causation and social selec-
tion/drift mechanisms to the well documented associ-
ation between socio-economic disadvantage and
depression in LMICs; to identify what specific interven-
tion strategies are needed to reach vulnerable low socio-
economic populations living with depression; and to
evaluate the effectiveness of interventions that are de-
signed to target each of the above mechanisms. Feasible
examples might include brief psychological interventions
with financial risk protection as part of universal health
coverage.
Conclusion
This study provides new evidence from South Africa in
support of the bidirectional relationship between poverty
and depression. Mental health interventions have been
shown to be associated with improved economic out-
comes in LMICs [16]. This study reinforces arguments
for the expansion of mental health services and improv-
ing the prevention, detection and treatment of depres-
sion in primary health care settings in South Africa and
other LMICs, for clinical and economic reasons. While
there is currently an emphasis on integrating communic-
able and non-communicable chronic disease care in
South Africa, we must not lose sight of the importance
of ensuring better management and access to mental
health care.
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